Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a consumer and described the occurrence of schizophrenia disorder in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On 11 September 2009, the subject received 2nd dose of CERVARIX (unknown route of administration, lot number not provided). On 11 September 2009, less than one day after vaccination with CERVARIX, the subject experienced nausea, vomiting, severe psychiatric disorder and schizophrenia disorder including recurrent thoughts of death and suicide (with a formal reporting recording the police office and the hospital on 18 September 2009). The subject was hospitalised. At the time of reporting the outcome of the events was unspecified.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166